Letter to the editor: Several issues to consider in the study of hepatocellular carcinoma progression mechanism

被引：0
|
作者：
Yang, Fan [1 ]
Jiang, Shi-Tao [1 ]
Lu, Xin [1 ]
Xu, Yiyao [1 ]
Zheng, Yong-Chang [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China
来源：
HEPATOLOGY | 2023年 / 78卷 / 01期
关键词：
D O I：
10.1002/hep.32659
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E1 / E2
页数：2
相关论文
共 50 条
  • [1] Several issues to consider in the study of hepatocellular carcinoma progression mechanism Reply
    Zhu, Hong
    Yang, Bo
    HEPATOLOGY, 2023, 78 (01) : E3 - E3
  • [2] The progression mechanism of hepatocellular carcinoma
    Osada, S.
    Imai, H.
    Sasaki, Y.
    Yoshida, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S134 - S135
  • [3] Alpha fetoprotein in hepatocellular carcinoma: Reply to letter to editor
    Farinati, Fabio
    Baldan, Anna
    Trevisani, Franco
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08): : 1940 - 1941
  • [4] Letter to the Editor: Inflammation influences the prognosis of hepatocellular carcinoma
    Xiao Liu
    Shunda Du
    International Journal of Clinical Oncology, 2022, 27 : 1791 - 1792
  • [5] Letter to the Editor: Inflammation influences the prognosis of hepatocellular carcinoma
    Liu, Xiao
    Du, Shunda
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (11) : 1791 - 1792
  • [6] Letter to the Editor: Refining the role of HAF in hepatocellular carcinoma
    Han, Jiashu
    Shan, Dan
    HEPATOLOGY, 2024,
  • [7] Letter to the editor: Aspirin use and the risk of hepatocellular carcinoma
    Lai, Shih-Wei
    HEPATOLOGY, 2022, 76 (06) : E138 - E139
  • [8] Letter to the editor:The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review
    Tsai, Wen-Han
    Liaw, Yung -Po
    CLINICAL NUTRITION, 2023, 42 (07)
  • [9] Letter to the Editor: Should Growth Pattern of Hepatocellular Carcinoma Be Constant and Homogenous?
    Wang, Haofan
    Mao, Yitao
    Huang, Mingsheng
    HEPATOLOGY, 2021, 73 (06) : 2617 - 2618
  • [10] Letter to the editor: Atezolizumab plus bevacizumab for hepatocellular carcinoma in the real world
    Zhang, Junwei
    Fang, Jinyu
    Xun, Ziyu
    Xu, Yiyao
    Lu, Xin
    Zhao, Haitao
    HEPATOLOGY, 2022, 76 (04) : E84 - E85
12345